Varicella and herpes zoster infections in immunocompromised host: prevention and treatment.
D000212:Acyclovir / Q000627:therapeutic use; D000917:Antibody Formation; D002644:Chickenpox / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D004198:Disease Susceptibility; D006562:Herpes Zoster / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D007372:Interferons / Q000627:therapeutic use; D012306:Risk; D014740:Vidarabine / Q000627:therapeutic use; D014775:Virus Activation; D005719:gamma-Globulins / Q000627:therapeutic use
D005719:gamma-Globulins; D007372:Interferons; D014740:Vidarabine; D000212:Acyclovir